** Shares of drug developer GeoVax Labs GOVX.O fall 16% to 89 cents in extended trading
** The U.S. Department of Health and Human Services has decided to terminate GeoVax's COVID-19 vaccine project contract — SEC filing
** The reason for the termination is stated as "convenience to the government"
** GeoVax received a stop-work notice from Advanced Technology International $(ATI)$ directing them to halt all activities related to the project
** The project was funded by the Biomedical Advanced Research and Development Authority (BARDA), a division of HHS
** The COVID-19 vaccine was in the mid-stage trial
** As of last close, stock fell 5.7% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。